伊拉克乳腺癌患者体内环氧化酶-2 和交联蛋白-6 的表达情况

Marwa Hussien
{"title":"伊拉克乳腺癌患者体内环氧化酶-2 和交联蛋白-6 的表达情况","authors":"Marwa Hussien","doi":"10.36330/kmj.v19i2.13259","DOIUrl":null,"url":null,"abstract":"Background: Breast cancer is one of the most common malignant tumors that endanger women's health internationally, relatively uncommon in men, accounting for only 1% of all cancer cases. Location, way of life, age at marriage, and obesity are a few environmental variables that increase the risk of breast cancer. Aim of study: the study aims to explain how the pro-inflammatory cytokines (IL-6) induce the inflammatory events in patients with breast cancer and to describe whether cyclooxygenase-2 promotes tumor growth in breast cancer or not. Materials and methods: The current case-control cross-sectional study included 45 patients with a history of breast cancer, and it was done in multiple places in Hilla, Babylon Province, between November 2022 and March 2023.Interlukin-6 and Cyclooxygenase-2 by QPCR. Results: The results have shown a significant increase of IL-6 (P < 0.05) in patients compared with control.  Also, the results have shown a significant increase (P < 0.05) of COX2 in patients compared with control. Conclusion: There is a significant increase in the means of Interlukin-6 and Cyclooxygenase-2 in the patients with breast cancer.","PeriodicalId":507092,"journal":{"name":"Kufa Medical Journal","volume":"37 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expression Of Cyclooxygenase-2 And Interlukin-6 Mrnas In Iraqi Patients With Breast Cancer\",\"authors\":\"Marwa Hussien\",\"doi\":\"10.36330/kmj.v19i2.13259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Breast cancer is one of the most common malignant tumors that endanger women's health internationally, relatively uncommon in men, accounting for only 1% of all cancer cases. Location, way of life, age at marriage, and obesity are a few environmental variables that increase the risk of breast cancer. Aim of study: the study aims to explain how the pro-inflammatory cytokines (IL-6) induce the inflammatory events in patients with breast cancer and to describe whether cyclooxygenase-2 promotes tumor growth in breast cancer or not. Materials and methods: The current case-control cross-sectional study included 45 patients with a history of breast cancer, and it was done in multiple places in Hilla, Babylon Province, between November 2022 and March 2023.Interlukin-6 and Cyclooxygenase-2 by QPCR. Results: The results have shown a significant increase of IL-6 (P < 0.05) in patients compared with control.  Also, the results have shown a significant increase (P < 0.05) of COX2 in patients compared with control. Conclusion: There is a significant increase in the means of Interlukin-6 and Cyclooxygenase-2 in the patients with breast cancer.\",\"PeriodicalId\":507092,\"journal\":{\"name\":\"Kufa Medical Journal\",\"volume\":\"37 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kufa Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36330/kmj.v19i2.13259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kufa Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36330/kmj.v19i2.13259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:乳腺癌是国际上危害妇女健康的最常见恶性肿瘤之一,在男性中相对少见,仅占所有癌症病例的 1%。地点、生活方式、结婚年龄和肥胖是增加乳腺癌风险的几个环境变量。研究目的:该研究旨在解释促炎细胞因子(IL-6)如何诱发乳腺癌患者的炎症事件,并描述环氧化酶-2是否会促进乳腺癌的肿瘤生长。材料和方法:本次病例对照横断面研究纳入了 45 名有乳腺癌病史的患者,研究于 2022 年 11 月至 2023 年 3 月期间在巴比伦省希拉市的多个地方进行。结果:结果显示,与对照组相比,患者体内的 IL-6 明显增加(P < 0.05)。 此外,与对照组相比,患者体内的 COX2 也明显增加(P < 0.05)。结论乳腺癌患者的白细胞介素-6 和环氧化酶-2 均有明显增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Expression Of Cyclooxygenase-2 And Interlukin-6 Mrnas In Iraqi Patients With Breast Cancer
Background: Breast cancer is one of the most common malignant tumors that endanger women's health internationally, relatively uncommon in men, accounting for only 1% of all cancer cases. Location, way of life, age at marriage, and obesity are a few environmental variables that increase the risk of breast cancer. Aim of study: the study aims to explain how the pro-inflammatory cytokines (IL-6) induce the inflammatory events in patients with breast cancer and to describe whether cyclooxygenase-2 promotes tumor growth in breast cancer or not. Materials and methods: The current case-control cross-sectional study included 45 patients with a history of breast cancer, and it was done in multiple places in Hilla, Babylon Province, between November 2022 and March 2023.Interlukin-6 and Cyclooxygenase-2 by QPCR. Results: The results have shown a significant increase of IL-6 (P < 0.05) in patients compared with control.  Also, the results have shown a significant increase (P < 0.05) of COX2 in patients compared with control. Conclusion: There is a significant increase in the means of Interlukin-6 and Cyclooxygenase-2 in the patients with breast cancer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信